Claritas Pharmaceuticals, Inc. Share Price
Stocks
CLAZF
CA1806342061
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 53.68L 38.52L 33.32L 31.11L 28.54L 37Cr 54.54L 3.65Cr 1.43Cr 18Cr 1.45Cr 1.41Cr 61Cr | P/E 2019 |
-0.74x | P/E 2020 | 0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 62.88L 45.12L 39.03L 36.45L 33.43L 43Cr 63.88L 4.28Cr 1.68Cr 22Cr 1.69Cr 1.66Cr 71Cr | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
99.74% | Yield 2019 * |
-
| Yield 2020 | - |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.4 |
| 10 years | 0 | | 15.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CEO | Chief Executive Officer | 76 | 21/06/2017 |
Victoria Rudman
DFI | Director of Finance/CFO | 58 | 29/06/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CHM | Chairman | 76 | 18/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/10/21 | Buy | 1,18,000 | 0.3332% | |||
| 11/10/21 | Buy | 1,52,500 | 0.4307% | |||
| 11/10/21 | Buy | 24,500 | 0.0692% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 37 | |
| +0.99% | +1.78% | +4.07% | +16.73% | 4.95TCr | |
| +3.71% | +9.40% | +486.98% | +592.14% | 4.36TCr | |
| +5.60% | +10.21% | +16.76% | +85.72% | 3.96TCr | |
| +2.70% | +1.57% | +33.39% | +8.85% | 3.93TCr | |
| +2.21% | +6.75% | +21.31% | +53.37% | 3.24TCr | |
| +2.23% | +4.71% | - | - | 1.68TCr | |
| +0.97% | +2.35% | +37.75% | +126.84% | 1.65TCr | |
| -0.11% | +2.41% | +6.24% | +18.87% | 1.4TCr | |
| +0.75% | +15.04% | +78.59% | +30.30% | 1.28TCr | |
| Average | +1.90% | +5.69% | +85.64% | +116.60% | 2.65TCr | |
| Weighted average by Cap. | +2.54% | +6.10% | +104.25% | +140.79% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.12Cr -1.52Cr -1.32Cr -1.23Cr -1.13Cr -144.84Cr -2.15Cr -14Cr -5.66Cr -73Cr -5.72Cr -5.59Cr -240.01Cr | 42.1L 30.21L 26.13L 24.4L 22.38L 29Cr 42.77L 2.86Cr 1.12Cr 14Cr 1.13Cr 1.11Cr 48Cr |
| Net Debt | 7L 5L 4L 4L 4L 4.81Cr 7L 47.87L 18.79L 2.41Cr 18.97L 18.55L 7.97Cr | 9L 7L 6L 5L 5L 6.28Cr 9L 62.56L 24.55L 3.15Cr 24.79L 24.24L 10Cr |
Employees
-
- Stock Market
- Stocks
- CLAZF Stock
Select your edition
All financial news and data tailored to specific country editions
